{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T08:17:19Z","timestamp":1791965839871,"version":"4.3.4"},"reference-count":20,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T00:00:00Z","timestamp":1650326400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain Sciences"],"abstract":"<jats:p>Introduction: Antiseizure medications (ASMs) control 70\u201375% of seizures. Accepting stress as a trigger for seizures, intervention, at the time of predictable stress, should offer a therapeutic option. Mode of intervention: Intervention requires the maintenance of an accurate seizure diary to identify a recurring pattern. With a questioning approach to that diary, the clinician may intervene when stressful provocateurs occur. Benzodiazepines, such as clobazam, initiated prior to the predictable stress, and continued until after it has passed, should be short lived, making serious adverse effects unlikely. Benzodiazepines have a dual benefit, being both anxietolytic and raising the seizure threshold in patients with epilepsy. Discussion: Many patients claim stress provokes their seizures and may not be aware the stress was the provocateur, until after a seizure occurred, leading to a retrospective claim of the relationship. To confirm the relationship, permitting preventative measures, before exposure to provocative factors, often unable to be avoided, requires maintenance and review of a detailed diary. Interval temporary use of benzodiazepines, such as clobazam, or alternatively clonazepam, diazepam or nitrazepam, offers a reasonable response to obviate subsequent seizures, and should be continued, for a brief period, after the risk has abated. Subsequent review of the diary, over a period of repeated exposures to the identified stress, will confirm or refute the therapeutic effect. Conclusion: Judicious use of interval therapy, with one of the benzodiazepines, covering the period of stressful provocation, offers adjunctive treatment of possible refractory epilepsy, based upon the review of the strictly maintained epilepsy\/seizure diary.<\/jats:p>","DOI":"10.3390\/brainsci12050512","type":"journal-article","created":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T02:39:31Z","timestamp":1650335971000},"page":"512","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Use of Interval Therapy with Benzodiazepines to Prevent Seizure Recurrence in Stressful Situations"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5884-0606","authenticated-orcid":false,"given":"Roy G.","family":"Beran","sequence":"first","affiliation":[{"name":"Neurology Department, Liverpool Hospital, Liverpool, NSW 2170, Australia"},{"name":"South Western Clinical School, University of New South Wales, Sydney, NSW 2170, Australia"},{"name":"Ingham Institute for Medical Research, South Western Sydney Area Health Service, Sydney, NSW 2170, Australia"},{"name":"School of Medicine, Griffith University, Southport, QLD 4215, Australia"},{"name":"Faculty of Sociology, Sechenov Moscow First State University, 119991 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,4,19]]},"reference":[{"key":"ref_1","first-page":"392","article-title":"Overview of drugs used for epilepsy and seizures: Etiology, diagnosis, and treatment","volume":"35","author":"Goldenberg","year":"2010","journal-title":"Pharm. Ther."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1001\/jamaneurol.2017.3949","article-title":"Treatment outcomes in patients with newly diagnosed epilepsy treated with established and new antiepileptic drugs. A 30-year longitudinal cohort study","volume":"75","author":"Chen","year":"2018","journal-title":"JAMA Neurol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1111\/epi.12377","article-title":"The role of stress as a trigger for epileptic seizures: A narrative review of evidence from humanand animal studies","volume":"54","author":"Novakova","year":"2013","journal-title":"Epilepsia"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1093\/brain\/awv157","article-title":"Relation between stress-precipitated seizures and the stress response in childhood epilepsy","volume":"138","author":"Jansen","year":"2015","journal-title":"Brain"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.yebeh.2009.06.004","article-title":"The lived experience of initial symptoms of and factors triggering epileptic seizures","volume":"15","author":"Pinikahana","year":"2009","journal-title":"Epilepsy Behav."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.yebeh.2016.10.036","article-title":"Subjective seizure counts by epilepsy clinical drug trial participants are not reliable","volume":"67","author":"Blachut","year":"2017","journal-title":"Epilepsy Behav."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1111\/epi.16630","article-title":"A new era in electroencephalographic monitoring? Subscalp devices for ultra-long-term recordings","volume":"61","author":"Baud","year":"2020","journal-title":"Epilepsia"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Airagnes, G., Lemogne, C., Renuy, A., Goldberg, M., Hoertel, N., Roquelaure, Y., Limosin, F., and Zins, M. (2019). Prevalence of prescribed benzodiazepine long-term use in the French general population according to sociodemographic and clinical factors: Findings from the CONSTANCES cohort. BMC Public Health, 19.","DOI":"10.1186\/s12889-019-6933-8"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"152","DOI":"10.18773\/austprescr.2015.055","article-title":"Management of benzodiazepine misuse and dependence","volume":"38","author":"Brett","year":"2015","journal-title":"Aust. Prescr."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1360-0443.1991.tb01831.x","article-title":"Benzodiazepine problems","volume":"86","author":"Lader","year":"1991","journal-title":"Br. J. Addict."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s11940-016-0401-x","article-title":"The role of benzodiazepines in the treatment of epilepsy","volume":"18","author":"Ochoa","year":"2016","journal-title":"Curr. Treat. Options Neurol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.yebeh.2007.12.013","article-title":"An Alternative Perspective on the Management of Status Epilepticus","volume":"12","author":"Beran","year":"2008","journal-title":"Epilepsy Behav."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.yebeh.2013.10.027","article-title":"Rectal carbamazepine as effective long-acting treatment after cluster seizures and status epilepticus","volume":"31","author":"Patel","year":"2014","journal-title":"Epilepsy Behav."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1755-5949.2010.00139.x","article-title":"Acute Administration of Benzodiazepines as Part of Treatment Strategies for Epilepsy","volume":"17","author":"Wolf","year":"2011","journal-title":"CNS Neurosci. Ther."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"535","DOI":"10.2147\/IJWH.S28872","article-title":"Diagnosis and management of catamenial seizures: A review","volume":"4","author":"Verrotti","year":"2012","journal-title":"Int. J. Women\u2019s Health"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1111\/j.1528-1157.1994.tb05978.x","article-title":"Clobazam in the treatment of epilepsy: A review of the literature","volume":"35","author":"Remy","year":"1994","journal-title":"Epilepsia"},{"key":"ref_17","first-page":"2121","article-title":"Addiction: Part I. Benzodiazepines\u2014Side Effects, Abuse Risk and Alternatives","volume":"61","author":"Longo","year":"2000","journal-title":"Am. Fam. Physician"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/cns.12399","article-title":"Clobazam: A Safe, Efficacious, and Newly Rediscovered Therapeutic for Epilepsy","volume":"21","author":"Gauthier","year":"2015","journal-title":"CNS Neurosci. Ther."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Jensen, H.S., Nichol, K., Lee, D., and Ebert, B. (2014). Clobazam and its active metabolite N-desmethylclobazam display significantly greater affinities for \u03b1\u2082- versus \u03b1\u2081-GABA(A)-receptor complexes. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0088456"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.yebeh.2014.05.016","article-title":"Withdrawal-related adverse events from clinical trials of clobazam in Lennox\u2013Gastaut syndrome","volume":"37","author":"Tolbert","year":"2014","journal-title":"Epilepsy Behav."}],"container-title":["Brain Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3425\/12\/5\/512\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:56:21Z","timestamp":1760136981000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3425\/12\/5\/512"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,19]]},"references-count":20,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,5]]}},"alternative-id":["brainsci12050512"],"URL":"https:\/\/doi.org\/10.3390\/brainsci12050512","relation":{},"ISSN":["2076-3425"],"issn-type":[{"value":"2076-3425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,19]]}}}